Markets
BUSINESS NEWS
- Market News
- Earnings
- Recalls
- Recession Watch
- Tech News
- Financial Crisis
- Madoff Scandal
- BloggingStocks
- Luxist
- Money Videos
INVESTING
- Stock Quotes
- Stock Charts
- Stock Ticker
- Currencies
- Portfolio
- Stock Screener
- Broker Center
- Mutual Fund Center
- ETF Center
- Money
- 24/7 Wall St.
- Financial Glossary
PERSONAL FINANCE AT WALLETPOP
- Bargains
- Banking
- Budget
- Calculators
- College Finance
- Community
- Credit
- Deals
- Debt
- Economizer
- Food
- Home
- Fraud
- Insurance
- Interest Rates
- Loans
- Mortgages
- Real Estate
- Recalls
- Recession
- Retirement
- Saving
- Simplification
- Specials
- Taxes
SMALL BUSINESS
Rigel Pharma to sell 6M shares in public offering
SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. said Wednesday it plans to offer 6 million shares of the company in a public offering.
The development-stage biotechnology company said it expects to grant underwriters an option to buy an additional 900,000 shares to cover over-allotments.
Rigel did not indicate how it would use net proceeds from the sale.
Credit Suisse Securities (USA) LLC will be acting as the sole book-runner for the offering, with Oppenheimer&Co. Inc. and Thomas Weisel Partners LLC acting as co-managers.
Shares of Rigel fell 44 cents, or 5.7 percent, to $7.22 in after-hours trading following the announcement of the offering. During the regular session, the stock climbed 5 cents to close at $7.66.